Inotiv Stock (NASDAQ:NOTV)


ForecastRevenueOwnershipFinancialsChartTranscripts

Previous Close

$3.84

52W Range

$1.23 - $11.42

50D Avg

$2.99

200D Avg

$3.26

Market Cap

$106.14M

Avg Vol (3M)

$666.20K

Beta

3.37

Div Yield

-

NOTV Company Profile


Inotiv, Inc. provides drug discovery and development services to the pharmaceutical, chemical, and medical device industries; and sells analytical instruments to the pharmaceutical development and contract research industries. It operates through two segments, Contract Research Services and Research Products. The Contract Research Services segment offers screening and pharmacological testing, nonclinical safety testing, formulation development, regulatory compliance, and quality control testing services. This segment provides analytical method development and validation; drug metabolism, bioanalysis, and pharmacokinetics testing to identify and measure drug and metabolite concentrations in complex biological matrices; in vivo sampling services for the continuous monitoring of chemical changes in life; stability testing to ensure the integrity of various solutions used in nonclinical and clinical studies, and post-study analyses; non-clinical toxicology and pathology services; and climate-controlled archiving services for its customers' data and samples. The Research Products segment designs, develops, manufactures, and markets in vivo sampling systems and accessories, including disposables, training, and systems qualification; physiology monitoring tools; liquid chromatography and electrochemistry instruments platforms; analytical products comprising liquid chromatographic and electrochemical instruments with associated accessories; and in vivo sampling products consisting of Culex family of automated in vivo sampling and dosing instruments. The company operates in the United States, rest of North America, the Pacific Rim, Europe, and internationally. It has an agreement with BioVaxys to conduct preclinical toxicity studies for its Covid-T Immunodiagnostic program. The company was formerly known as Bioanalytical Systems, Inc. and changed its name to Inotiv, Inc. in March 2021. Inotiv, Inc. was founded in 1974 and is headquartered in West Lafayette, Indiana.

Show More

Industry

Medical - Diagnostics & Research

Sector

Healthcare

Exchange

NASDAQ

ADR

-

Country

US

Employees

1,955

IPO Date

Nov 25, 1997

Website

NOTV Performance


Revenue Breakdown


Revenue Breakdown by Product/Service

Product/ServiceSep 24Sep 23Sep 22
Service$219.66M$223.81M-
Product$271.08M$348.61M-
Intersegment--$7.25M

Fiscal year ends in Sep 24 | Currency in USD

NOTV Financial Summary


Sep 24Sep 23Sep 22
Revenue$490.74M$572.42M$547.66M
Operating Income$-86.41M$-81.46M$-27.45M
Net Income$-152.63M$-105.14M$-337.26M
EBITDA$-120.53M$-26.51M$-273.42M
Basic EPS$-5.89$-4.10$-13.85
Diluted EPS$-5.89$-4.10$-13.85

Fiscal year ends in Sep 24 | Currency in USD

Latest Earnings Call Transcripts


Q4 24Dec 03, 24 | 6:22 PM
Q3 24Aug 08, 24 | 10:55 PM
Q2 24May 15, 24 | 10:05 PM

Peer Comparison


TickerCompany
SERASera Prognostics, Inc.
DRIODarioHealth Corp.
XGNExagen Inc.
BNRBurning Rock Biotech Limited
FONRFONAR Corporation
STIMNeuronetics, Inc.
SHCSotera Health Company
MDXHMDxHealth SA